In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Dallas and Phoenix labs. The ability to test healthcare partner samples at any one of the three labs is a critical element in creating the reliability the CTS healthcare partners desire so they can provide the blood that saves patients’ lives.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...